These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24552991)

  • 1. New trends in the neurobiology and pharmacology of affective disorders.
    Lasoń W; Budziszewska B; Basta-Kaim A; Kubera M; Maes M
    Pharmacol Rep; 2013; 65(6):1441-50. PubMed ID: 24552991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of antidepressants: clinical pharmacology and therapy.
    Baldessarini RJ
    J Clin Psychiatry; 1989 Apr; 50(4):117-26. PubMed ID: 2647712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence.
    Ferrari F; Villa RF
    Mol Neurobiol; 2017 Sep; 54(7):4847-4865. PubMed ID: 27510505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action.
    Sanacora G; Saricicek A
    CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):127-40. PubMed ID: 17430150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurobiology of depression and antidepressant action.
    Willner P; Scheel-Krüger J; Belzung C
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 1):2331-71. PubMed ID: 23261405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Depression and neuroplasticity].
    Pitchot W; Polis M; Belachew S; Ansseau M
    Rev Med Liege; 2008; 63(5-6):372-7. PubMed ID: 18669207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate receptors in the control of mood disorders.
    Witkin JM; Marek GJ; Johnson BG; Schoepp DD
    CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):87-100. PubMed ID: 17430147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress markers in affective disorders.
    Siwek M; Sowa-Kućma M; Dudek D; Styczeń K; Szewczyk B; Kotarska K; Misztakk P; Pilc A; Wolak M; Nowak G
    Pharmacol Rep; 2013; 65(6):1558-71. PubMed ID: 24553004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptides in depression: role of VGF.
    Thakker-Varia S; Alder J
    Behav Brain Res; 2009 Feb; 197(2):262-78. PubMed ID: 18983874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult hippocampal neurogenesis: an actor in the antidepressant-like action.
    Mendez-David I; Hen R; Gardier AM; David DJ
    Ann Pharm Fr; 2013 May; 71(3):143-9. PubMed ID: 23622692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain.
    Blier P; Abbott FV
    J Psychiatry Neurosci; 2001 Jan; 26(1):37-43. PubMed ID: 11212592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared mechanisms of antidepressant and antiepileptic treatments: drugs and devices.
    Jobe PC
    Clin EEG Neurosci; 2004 Jan; 35(1):25-37. PubMed ID: 15112461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astroglial Connexin43 as a Potential Target for a Mood Stabiliser.
    Okada M; Oka T; Nakamoto M; Fukuyama K; Shiroyama T
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant drugs and cytokines in mood disorders.
    Nishida A; Hisaoka K; Zensho H; Uchitomi Y; Morinobu S; Yamawaki S
    Int Immunopharmacol; 2002 Nov; 2(12):1619-26. PubMed ID: 12469936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants.
    Hill MN; Hillard CJ; Bambico FR; Patel S; Gorzalka BB; Gobbi G
    Trends Pharmacol Sci; 2009 Sep; 30(9):484-93. PubMed ID: 19732971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches.
    Jobe PC
    Clin EEG Neurosci; 2004 Jan; 35(1):53-68. PubMed ID: 15112464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotrophins in depression and antidepressant effects.
    Castrén E; Rantamäki T
    Novartis Found Symp; 2008; 289():43-52; discussion 53-9, 87-93. PubMed ID: 18497094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological brain changes in depression: can antidepressants reverse them?
    Miguel-Hidalgo JJ; Rajkowska G
    CNS Drugs; 2002; 16(6):361-72. PubMed ID: 12027783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin in health and disease with a focus on affective disorders.
    Zelena D
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):286-303. PubMed ID: 22954353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.